GlassScriptPhysician profile
Ethan Patrick Baham
NPI 1740635556
$3,924.07
in general payments reported to CMS, 2019-2025
55 companies · $558 in 2025
The $558 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $571 · 2021: $520 · 2022: $562 · 2023: $853 · 2024: $623 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,034.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $643.44 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $366.68 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $329.18 | 2019-2025 | Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $268.18 | 2020-2025 | Arexvy, Shingrix |
| Pfizer INC. | $254.32 | 2019-2025 | |
| Dynavax Technologies Corporation | $177.89 | 2019-2025 | Heplisav-B |
| Astrazeneca Pharmaceuticals LP | $156.61 | 2020-2025 | Breztri, Airsupra |
| Kyowa Kirin, INC. | $148.76 | 2023-2025 | Crysvita |
| Amarin Pharma, INC. | $110.22 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $97.05 | 2020-2024 | Spravato |
| Merck Sharp & Dohme LLC | $94.65 | 2020-2023 | Pneumovax 23, Vaxneuvance, Proquad |
| Sanofi-Aventis U.S. LLC | $85.21 | 2020-2024 | |
| Cranial Technologies, INC | $74.36 | 2019-2025 | Doc Band |
| Astellas Pharma US INC | $73.52 | 2020-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $69.32 | 2020-2022 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Baham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.